Cancer Treatment –Related Complications in Patients With Hypertrophic Cardiomyopathy

To describe the potential clinical cardiotoxicity of oncological treatments in a cohort of consecutive patients with hypertrophic cardiomyopathy (HCM), systematically followed-up at two national referral centers for HCM. Cardiotoxicity relates to the direct effects of cancer-related treatment on heart function, commonly presenting as left ventricular contractile dysfunction. However, limited data are available regarding cardiotoxic effects on HCM as most studies have not specifically analyzed the effects of oncological treatment in HCM populations.

Source: Mayo Clinic Proceedings - January 4, 2024 Category: Internal Medicine Authors: Mattia Zampieri, Stephan A.C. Schoonvelde, Michele Vinci, Icro Meattini, Luca Visani, Alessandra Fornaro, Raffaele Coppini, Andrea Romei, Alberto Marchi, Ilaria Morelli, Marjon A. van Slegtenhorst, Eszter Dalma Palinkas, Lorenzo Livi, Michelle Michels, Ia Tags: Original Article Source Type: research